Challenges in preclinical characterization of nanomedicines
- At: 2014 FIP Congress in PSWC, Melbourne (Australia)
- Type: Presentation
- By: DOBROVOLSKAIA, Marina (Leidos Biomedical Research Inc, Frederick National Laboratory for Cancer Researc, CRTP/NCL, Frederick, md, United States of America)
Background: Nanomedicine is rapidly growing field. Many nanoformulations have been granted regulatory approval for use in medical applications, while many more are in various phases of preclinical and clinical development. Aims: To review experience of NCI-Nanotechnology Characterization Laboratory with preclinical characterization of.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.